241 filings
Page 3 of 13
8-K
e1c0nhpo0
13 Jan 22
ProPhase Labs Announces Record COVID-19 Testing in Q4 2021
8:20am
8-K
opn6cm6p453
4 Jan 22
Departure of Directors or Certain Officers
6:05am
8-K
fl1e60mj
29 Dec 21
Entry into a Material Definitive Agreement
4:10pm
8-K
gtpnqf47osn wrt
12 Nov 21
ProPhase Labs Announces Financial Results
8:45am
8-K
bj142vvm73sn
13 Oct 21
ProPhase Labs Provides Business Update
8:35am
8-K
fnv6b28i95a1
8 Sep 21
ProPhase Labs Announces $6 Million Stock Repurchase Program
4:15pm
8-K
8j6g0ho4zy
16 Aug 21
ProPhase Labs Acquires Whole Genome Sequencing Company, Nebula Genomics
4:49pm
8-K
t840wp315369
13 Aug 21
Company Provides Update on Significant Resurgence in Covid testing and Additional Insights into Previously Announced Nebula Genomics Acquisition
8:14am
8-K
qkc7mee0mm7kc n8m
15 Jun 21
Departure of Directors or Certain Officers
6:05am
8-K
11qzt l53qz6eil
11 Jun 21
Regulation FD Disclosure
12:00am
8-K
b7g7wfn
28 May 21
ProPhase Labs to Present at LD Micro Invitational XI Virtual Conference
8:35am
8-K
keif3
21 May 21
Departure of Directors or Certain Officers
8:30am
8-K
pmfakbuyb czl31
13 May 21
ProPhase Labs Reports First Quarter 2021 Financial Results
4:23pm
8-K
x6rc511k0zph8zdv
5 Apr 21
ProPhase Labs Reports Fourth Quarter and Full Year 2020 Financial Results
8:51am
8-K
wxpate8ayyj254e6ap7y
17 Mar 21
Regulation FD Disclosure
11:57am
8-K
0c30v qft
1 Feb 21
Regulation FD Disclosure
8:35am
8-K
0o7z8ce
20 Jan 21
ProPhase Labs Announces Proposed Public Offering of Common Stock
4:15pm
8-K
gtb07jg j2btdbmc
15 Jan 21
Entry into a Material Definitive Agreement
7:46am
8-K
cusktuoa66u1e
7 Jan 21
ProPhase Labs Announces $5.5 Million Registered Direct Offering of Common Stock and Warrants
8:05am
8-K/A
r4hts
4 Jan 21
Financial Statements and Exhibits
4:30pm